Related Experiment Video
Updated: Jan 25, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Mould-reactive T cells for the diagnosis of invasive mould infection-A prospective study
Angela Steinbach1,2,3, Oliver A Cornely1,2,3,4,5, Hilmar Wisplinghoff6,7,8
1Faculty of Medicine, Department I of Internal Medicine, University of Cologne, Cologne, Germany.
Abstract:
Invasive mould infections (IMI) in immunocompromised patients are difficult to diagnose. Early and targeted treatment is paramount, but minimally invasive tests reliably identifying pathogens are lacking. We previously showed that monitoring pathogen-specific CD4+T cells in peripheral blood using upregulation of induced CD154 positive lymphocytes can be used to diagnose acute IMI. Here, we validate our findings in an independent patient cohort. We stimulated peripheral blood cells from at-risk patients with Aspergillus spp. and Mucorales lysates and quantitated mould-reactive CD4/CD69/CD154 positive lymphocytes via flow cytometry. Mould-reactive lymphocytes were quantitated in 115 at-risk patients. In 38 (33%) patients, the test was not evaluable, mainly due to low T cell counts or non-reactive positive control. Test results were evaluable in 77 (67%) patients. Of these, four patients (5%) had proven IMI and elevated mould-reactive T cell signals. Of 73 (95%) patients without proven IMI, 59 (81%) had mould-reactive T cell signals within normal range. Fourteen (19%) patients without confirmed IMI showed elevated T cell signals and 11 of those received antifungal treatment. The mould-reactive lymphocyte assay identified presence of IMI with a sensitivity of 100% and specificity of 81%. The mould-reactive lymphocyte assay correctly identified all patients with proven IMI. Assay applicability is limited by low T cell counts during bone marrow suppression. The assay has the potential to support diagnosis of invasive mould infection to facilitate tailored treatment even when biopsies are contraindicated or cultures remain negative.
Insights
Diagnosing invasive mould infections (IMI) in immunocompromised patients is challenging. A new assay monitoring mould-reactive T cells shows promise for early IMI detection, aiding targeted antifungal treatment.
Area of Science:
- Medical Mycology
- Immunology
- Clinical Diagnostics
Background:
- Invasive mould infections (IMI) pose a significant diagnostic challenge in immunocompromised individuals.
- Current diagnostic methods often lack the speed and specificity required for timely intervention.
- Minimally invasive tests for reliable pathogen identification are critically needed.
Purpose of the Study:
- To validate a previously developed assay for diagnosing acute IMI.
- To assess the utility of monitoring mould-reactive CD4+ T cells in peripheral blood.
- To evaluate the assay's performance in an independent patient cohort.
Main Methods:
- Peripheral blood cells from at-risk patients were stimulated with Aspergillus spp. and Mucorales lysates.
- Mould-reactive CD4/CD69/CD154 positive lymphocytes were quantified using flow cytometry.
- The assay's sensitivity and specificity for IMI detection were determined.
Main Results:
- The mould-reactive lymphocyte assay was evaluable in 77% of patients.
- A sensitivity of 100% and specificity of 81% were observed for IMI detection.
- The assay correctly identified all patients with proven IMI, but applicability was limited by low T cell counts.
Conclusions:
- The mould-reactive lymphocyte assay demonstrates high sensitivity for diagnosing IMI.
- This assay can potentially support early, tailored treatment decisions for invasive mould infections.
- Further validation is needed, especially in patients with severe bone marrow suppression.
More Related Videos
Related Concept Videos
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Cross-reactivity
Reactivity of Enols
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
Reactivity of Enolate Ions
Formulating and Validating Nursing Diagnosis I
There are thirteen domains...

